These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37336069)

  • 1. Development and therapeutic potential of allosteric retinoic acid receptor-related orphan receptor γt (RORγt) inverse agonists for autoimmune diseases.
    Lu L; Sun N; Wang Y
    Eur J Med Chem; 2023 Oct; 258():115574. PubMed ID: 37336069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineation of the molecular determinants of the unique allosteric binding site of the orphan nuclear receptor RORγt.
    Leijten-van de Gevel IA; Brunsveld L
    J Biol Chem; 2020 Jul; 295(27):9183-9191. PubMed ID: 32439807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modes of action insights from the crystallographic structures of retinoic acid receptor-related orphan receptor-γt (RORγt).
    Zhang J; Chen B; Zhang C; Sun N; Huang X; Wang W; Fu W
    Eur J Med Chem; 2023 Feb; 247():115039. PubMed ID: 36566711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel triazine derivatives as potent retinoic acid receptor-related orphan receptor γt (RORγt) inverse agonists.
    Lu L; Chen S; Yu M; Zhou R; Guo S; Chen JA; Wang H; Chen S; Luo C; Xie Q; Wang Y
    Eur J Med Chem; 2023 Aug; 256():115424. PubMed ID: 37167779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-Based Design of Allosteric Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Inverse Agonists.
    Meijer FA; Doveston RG; de Vries RMJM; Vos GM; Vos AAA; Leysen S; Scheepstra M; Ottmann C; Milroy LG; Brunsveld L
    J Med Chem; 2020 Jan; 63(1):241-259. PubMed ID: 31821760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics simulations on RORγt: insights into its functional agonism and inverse agonism.
    Yuan CM; Chen HH; Sun NN; Ma XJ; Xu J; Fu W
    Acta Pharmacol Sin; 2019 Nov; 40(11):1480-1489. PubMed ID: 31316175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (Inverse) Agonists of Retinoic Acid-Related Orphan Receptor γ: Regulation of Immune Responses, Inflammation, and Autoimmune Disease.
    Jetten AM; Cook DN
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():371-390. PubMed ID: 31386594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist Lock Touched and Untouched Retinoic Acid Receptor-Related Orphan Receptor-γt (RORγt) Inverse Agonists: Classification Based on the Molecular Mechanisms of Action.
    Sun N; Xie Q; Dang Y; Wang Y
    J Med Chem; 2021 Aug; 64(15):10519-10536. PubMed ID: 34264059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of N-indanyl benzamides as potent RORγt inverse agonists.
    Tian J; Sun N; Yu M; Gu X; Xie Q; Shao L; Liu J; Liu L; Wang Y
    Eur J Med Chem; 2019 Apr; 167():37-48. PubMed ID: 30743096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 2H-chromone-4-one based sulfonamide derivatives as potent retinoic acid receptor-related orphan receptor γt inverse agonists.
    Chen L; Su M; Wu XZ; Wang DZ; Kang YY; Wang CG; Assani I; Wang MX; Zhao SF; Lv SM; Wang JW; Sun B; Li Y; Jin Q; Huang RZ; Liao ZX
    Eur J Med Chem; 2022 Feb; 229():114065. PubMed ID: 34971876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural studies unravel the active conformation of apo RORγt nuclear receptor and a common inverse agonism of two diverse classes of RORγt inhibitors.
    Li X; Anderson M; Collin D; Muegge I; Wan J; Brennan D; Kugler S; Terenzio D; Kennedy C; Lin S; Labadia ME; Cook B; Hughes R; Farrow NA
    J Biol Chem; 2017 Jul; 292(28):11618-11630. PubMed ID: 28546429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel series of cysteine-dependent, allosteric inverse agonists of the nuclear receptor RORγt.
    Jiang X; Dulubova I; Reisman SA; Hotema M; Lee CI; Liu L; McCauley L; Trevino I; Ferguson DA; Eken Y; Wilson AK; Wigley WC; Visnick M
    Bioorg Med Chem Lett; 2020 Mar; 30(6):126967. PubMed ID: 32005415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Activity Relationship Studies of Trisubstituted Isoxazoles as Selective Allosteric Ligands for the Retinoic-Acid-Receptor-Related Orphan Receptor γt.
    Meijer FA; Saris AOWM; Doveston RG; Oerlemans GJM; de Vries RMJM; Somsen BA; Unger A; Klebl B; Ottmann C; Cossar PJ; Brunsveld L
    J Med Chem; 2021 Jul; 64(13):9238-9258. PubMed ID: 34008974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, and Biological Evaluation of Retinoic Acid-Related Orphan Receptor γt (RORγt) Agonist Structure-Based Functionality Switching Approach from In House RORγt Inverse Agonist to RORγt Agonist.
    Yukawa T; Nara Y; Kono M; Sato A; Oda T; Takagi T; Sato T; Banno Y; Taya N; Imada T; Shiokawa Z; Negoro N; Kawamoto T; Koyama R; Uchiyama N; Skene R; Hoffman I; Chen CH; Sang B; Snell G; Katsuyama R; Yamamoto S; Shirai J
    J Med Chem; 2019 Feb; 62(3):1167-1179. PubMed ID: 30652849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγt.
    Gege C; Albers M; Kinzel O; Kleymann G; Schlüter T; Steeneck C; Hoffmann T; Xue X; Cummings MD; Spurlino J; Milligan C; Fourie AM; Edwards JP; Leonard K; Coe K; Scott B; Pippel D; Goldberg SD
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127205. PubMed ID: 32336498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidation of an Allosteric Mode of Action for a Thienopyrazole RORγt Inverse Agonist.
    de Vries RMJM; Doveston RG; Meijer FA; Brunsveld L
    ChemMedChem; 2020 Apr; 15(7):561-565. PubMed ID: 32053744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Biological Evaluation of New Triazolo- and Imidazolopyridine RORγt Inverse Agonists.
    Hintermann S; Guntermann C; Mattes H; Carcache DA; Wagner J; Vulpetti A; Billich A; Dawson J; Kaupmann K; Kallen J; Stringer R; Orain D
    ChemMedChem; 2016 Dec; 11(24):2640-2648. PubMed ID: 27902884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecules targeting RORγt inhibit autoimmune disease by suppressing Th17 cell differentiation.
    Tan J; Liu H; Huang M; Li N; Tang S; Meng J; Tang S; Zhou H; Kijlstra A; Yang P; Hou S
    Cell Death Dis; 2020 Aug; 11(8):697. PubMed ID: 32829384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthosteric and Allosteric Dual Targeting of the Nuclear Receptor RORγt with a Bitopic Ligand.
    Meijer FA; Oerlemans GJM; Brunsveld L
    ACS Chem Biol; 2021 Mar; 16(3):510-519. PubMed ID: 33596047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of [ cis-3-({(5 R)-5-[(7-Fluoro-1,1-dimethyl-2,3-dihydro-1 H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5 H)-yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist.
    Kono M; Ochida A; Oda T; Imada T; Banno Y; Taya N; Masada S; Kawamoto T; Yonemori K; Nara Y; Fukase Y; Yukawa T; Tokuhara H; Skene R; Sang BC; Hoffman ID; Snell GP; Uga K; Shibata A; Igaki K; Nakamura Y; Nakagawa H; Tsuchimori N; Yamasaki M; Shirai J; Yamamoto S
    J Med Chem; 2018 Apr; 61(7):2973-2988. PubMed ID: 29510038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.